Charles River Laboratories International
CRL
Charles River Laboratories International (CRL) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Morgan Stanley | Maintained | Overweight | $340.00 from $300.00 | Oct 13, 2026 |
| UBS | Maintained | Buy | $357.00 | Sep 30, 2026 |
| Jefferies | Maintained | Buy | $340.00 from $305.00 | Sep 28, 2026 |
| Baird | Maintained | Outperform | $334.00 from $291.00 | Sep 25, 2026 |
| Mizuho | Maintained | Neutral | $295.00 from $264.00 | Sep 25, 2026 |
| Barclays | Maintained | Overweight | $330.00 from $300.00 | Sep 25, 2026 |
| RBC Capital | Maintained | Outperform | $322.00 from $282.00 | Sep 25, 2026 |
| Evercore ISI Group | Maintained | Outperform | $330.00 from $320.00 | Sep 25, 2026 |
| TD Cowen | Maintained | Buy | $325.00 from $300.00 | Sep 25, 2026 |
| Deutsche Bank | Maintained | Buy | $320.00 from $300.00 | Sep 25, 2026 |
| Evercore ISI Group | Maintained | Outperform | $320.00 from $300.00 | Sep 11, 2026 |
| TD Cowen | Maintained | Buy | $300.00 from $235.00 | Aug 10, 2026 |
| Morgan Stanley | Maintained | Overweight | $300.00 from $260.00 | Aug 7, 2026 |
| JP Morgan | Upgraded | Neutral → Overweight | $310.00 from $180.00 | Aug 6, 2026 |
| Evercore ISI Group | Maintained | Outperform | $300.00 from $260.00 | Aug 6, 2026 |
| RBC Capital | Maintained | Outperform | $282.00 from $215.00 | Aug 6, 2026 |
| CLSA | Downgraded | Outperform → Hold | $219.00 | Jul 20, 2026 |
| Mizuho | Maintained | Neutral | $230.00 from $192.00 | Jul 13, 2026 |
| Morgan Stanley | Maintained | Overweight | $260.00 from $220.00 | Jul 9, 2026 |
| Morgan Stanley | Upgraded | Equal-Weight → Overweight | $220.00 from $185.00 | Jun 17, 2026 |
Frequently asked questions
What is the latest analyst rating on CRL?
On Oct 13, 2026, Morgan Stanley maintained Charles River Laboratories International at Overweight with a price target of $340.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.